Real-world clinical and economic outcomes for daily teriparatide patients in Japan.

about

Real-world effectiveness of daily teriparatide in Japanese patients with osteoporosis at high risk for fracture: final results from the 24-month Japan Fracture Observational Study (JFOS).

P2860

Q47701411-30A4D235-0E5E-430F-8213-62FF894A285C

P2860

Real-world clinical and economic outcomes for daily teriparatide patients in Japan.

Item

http://www.wikidata.org/entity/Q40506119

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Real-world clinical and economic outcomes for daily teriparatide patients in Japan.

@en

type

Item

label

Real-world clinical and economic outcomes for daily teriparatide patients in Japan.

@en

prefLabel

Real-world clinical and economic outcomes for daily teriparatide patients in Japan.

@en

P1476

Real-world clinical and economic outcomes for daily teriparatide patients in Japan.

@en

P2093

Masayo Sato

http://www.w3.org/2001/XMLSchema#string

Russel Burge

http://www.w3.org/2001/XMLSchema#string

Tomoko Sugihara

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Identification and validation of vertebral compression fractures using administrative claims data.

Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS).

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Anti-epileptic medication and bone health.

Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis

Loss of treatment benefit due to low compliance with bisphosphonate therapy.

Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.

P2888

s00774-015-0720-0

P304

692-702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00774-015-0720-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

286476868

http://www.w3.org/2001/XMLSchema#string

P6179

1043396193

http://www.w3.org/2001/XMLSchema#string

P698

26661475

http://www.w3.org/2001/XMLSchema#string

Real-world clinical and economic outcomes for daily teriparatide patients in Japan.

about

P2860

P2860

Real-world clinical and economic outcomes for daily teriparatide patients in Japan.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698